These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22215265)

  • 1. Impact of delaying blood pressure control in patients with Type 2 diabetes: results of a decision analysis.
    Laiteerapong N; John PM; Meltzer DO; Huang ES
    J Gen Intern Med; 2012 Jun; 27(6):640-6. PubMed ID: 22215265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of changes in HbA1c, lipids and blood pressure on long-term outcomes in type 2 diabetes patients: an analysis using the CORE Diabetes Model.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Hayes C; Oglesby A; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S53-8. PubMed ID: 15324516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What impact would pancreatic beta-cell preservation have on life expectancy, quality-adjusted life expectancy and costs of complications in patients with type 2 diabetes? A projection using the CORE Diabetes Model.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Lammert M; Oglesby A; Hayes C; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S59-66. PubMed ID: 15324517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy.
    Jia H; Zack MM; Thompson WW
    Value Health; 2013; 16(1):140-7. PubMed ID: 23337225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Lammert M; Nicklasson L; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S67-73. PubMed ID: 15324518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey.
    Reynoso-Noverón N; Mehta R; Almeda-Valdes P; Rojas-Martinez R; Villalpando S; Hernández-Ávila M; Aguilar-Salinas CA
    Cardiovasc Diabetol; 2011 Jan; 10():1. PubMed ID: 21214916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).
    Stratton IM; Cull CA; Adler AI; Matthews DR; Neil HA; Holman RR
    Diabetologia; 2006 Aug; 49(8):1761-9. PubMed ID: 16736131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).
    Clarke PM; Gray AM; Briggs A; Stevens RJ; Matthews DR; Holman RR;
    Diabetologia; 2005 May; 48(5):868-77. PubMed ID: 15834550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group.
    UK Prospective Diabetes Study Group
    BMJ; 1998 Sep; 317(7160):720-6. PubMed ID: 9732339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
    Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
    Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of different systolic blood pressure targets for people with a history of stroke or transient ischaemic attack: Economic analysis of the PAST-BP study.
    Penaloza-Ramos MC; Jowett S; Barton P; Roalfe A; Fletcher K; Taylor CJ; Hobbs FR; McManus RJ; Mant J
    Eur J Prev Cardiol; 2016 Oct; 23(15):1590-8. PubMed ID: 27226338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria modifies the effect of systolic blood pressure on total and cardiovascular disease mortality in patients with type 2 diabetes.
    Vepsäläinen T; Laakso M; Kantola I; Lehto S; Juutilainen A; Rönnemaa T
    J Intern Med; 2012 Dec; 272(6):611-9. PubMed ID: 22891848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of depression on quality-adjusted life expectancy (QALE) directly as well as indirectly through suicide.
    Jia H; Zack MM; Thompson WW; Crosby AE; Gottesman II
    Soc Psychiatry Psychiatr Epidemiol; 2015 Jun; 50(6):939-49. PubMed ID: 25660550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality-adjusted life expectancy (QALE) loss due to smoking in the United States.
    Jia H; Zack MM; Thompson WW; Dube SR
    Qual Life Res; 2013 Feb; 22(1):27-35. PubMed ID: 22350530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
    Adler AI; Stratton IM; Neil HA; Yudkin JS; Matthews DR; Cull CA; Wright AD; Turner RC; Holman RR
    BMJ; 2000 Aug; 321(7258):412-9. PubMed ID: 10938049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulating the impact of targeting lower systolic blood pressure and LDL-cholesterol levels on type 2 diabetes complication rates.
    Mostafa SA; Coleman RL; Agbaje OF; Gray AM; Holman RR; Bethel MA
    J Diabetes Complications; 2019 Jan; 33(1):69-74. PubMed ID: 30361000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a survey to estimate health expectancy and quality-adjusted life expectancy to assess inequalities in health and quality of life.
    Collins B
    Value Health; 2013 Jun; 16(4):599-603. PubMed ID: 23796294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastolic orthostatic hypertension and cardiovascular prognosis in type 2 diabetes: a prospective cohort study.
    Wijkman M; Länne T; Östgren CJ; Nystrom FH
    Cardiovasc Diabetol; 2016 Jun; 15():83. PubMed ID: 27255168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cost-effectiveness of pioglitazone versus placebo in addition to existing diabetes treatment: a US analysis based on PROactive.
    Valentine WJ; Tucker D; Palmer AJ; Minshall ME; Foos V; Silberman C;
    Value Health; 2009; 12(1):1-9. PubMed ID: 18657104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study.
    Vamos EP; Harris M; Millett C; Pape UJ; Khunti K; Curcin V; Molokhia M; Majeed A
    BMJ; 2012 Aug; 345():e5567. PubMed ID: 22936794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.